337 results on '"McDevitt, Michael R."'
Search Results
2. Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
3. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
4. [18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response
5. Alpha-Emitting Radionuclides: Current Status and Future Perspectives
6. [89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma
7. Targeted melanoma radiotherapy using ultrasmall 177Lu-labeled α-melanocyte stimulating hormone-functionalized core-shell silica nanoparticles
8. Deconvoluting hepatic processing of carbon nanotubes.
9. Fibrillar pharmacology of functionalized nanocellulose
10. Radiopharmaceutical therapy in cancer: clinical advances and challenges
11. Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma
12. Supplementary Figures 1 and 2 from Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
13. Data from Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
14. Tumor Therapy with Targeted Atomic Nanogenerators
15. Supplementary Figure S1 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
16. Figure S1 from A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
17. Supplementary Data from Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
18. Supplementary Methods from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
19. Supplementary Table S1 from PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
20. Data from Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors
21. Supplementary Methods, Figures 1-3 from Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors
22. Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
23. Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
24. Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
25. Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challenges
26. Mechanism of a dinuclear copper complex catalyzed autoxidation of 3,5-di-tert-butylcatechol
27. Carbon nanotubes as vaccine scaffolds
28. Assessing Functional Androgen Receptor Pathway Activity in Response to Radiotherapy Using hK2-targeted PET Imaging
29. [18F]-Labeled PARP-1 PET Imaging of PSMA Targeted Alpha Particle Radiotherapy Response
30. Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
31. Preface
32. Alpha Particles Induce Apoptosis through the Sphingomyelin Pathway
33. Paradoxical glomerular filtration of carbon nanotubes
34. Abstract P168: Pretargeted radioimmunotherapy using 225Ac for intraperitoneal Her2-expressing epithelial ovarian carcinoma xenografts
35. Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides
36. [89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma
37. Abstract 3056: Alpha particle radiobiology and the treatment of prostate adenocarcinoma
38. [18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response.
39. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
40. Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
41. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
42. PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
43. Carbon Nanotubes
44. Immunoreactivity assay for [formula omitted]-particle emitting monoclonal antibody constructs
45. A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia
46. PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates
47. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles
48. Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses
49. Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
50. Radioimmunotherapy with alpha-emitting nuclides
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.